Truffle Hound Capital LLC reduced its holdings in shares of TruBridge, Inc. (NASDAQ:TBRG - Free Report) by 43.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 170,000 shares of the company's stock after selling 130,000 shares during the period. TruBridge makes up 1.7% of Truffle Hound Capital LLC's investment portfolio, making the stock its 15th largest holding. Truffle Hound Capital LLC owned about 1.14% of TruBridge worth $4,678,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Covestor Ltd boosted its stake in shares of TruBridge by 20.5% in the fourth quarter. Covestor Ltd now owns 2,819 shares of the company's stock valued at $56,000 after buying an additional 479 shares in the last quarter. Cubist Systematic Strategies LLC boosted its stake in shares of TruBridge by 2.0% during the 4th quarter. Cubist Systematic Strategies LLC now owns 26,202 shares of the company's stock worth $517,000 after acquiring an additional 514 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in TruBridge by 47.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,170 shares of the company's stock worth $43,000 after purchasing an additional 699 shares during the last quarter. Trexquant Investment LP raised its stake in shares of TruBridge by 14.4% during the 4th quarter. Trexquant Investment LP now owns 16,760 shares of the company's stock worth $331,000 after buying an additional 2,112 shares during the last quarter. Finally, Forest Hill Capital LLC increased its stake in shares of TruBridge by 5.3% during the 4th quarter. Forest Hill Capital LLC now owns 148,184 shares of the company's stock worth $2,922,000 after purchasing an additional 7,500 shares in the last quarter. 88.64% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, Stephens reaffirmed an "equal weight" rating and issued a $28.00 target price on shares of TruBridge in a research note on Thursday, April 10th.
Get Our Latest Report on TruBridge
TruBridge Stock Up 2.1%
TBRG traded up $0.44 on Wednesday, reaching $21.33. The company's stock had a trading volume of 96,136 shares, compared to its average volume of 170,158. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.69 and a quick ratio of 1.68. TruBridge, Inc. has a 1 year low of $9.83 and a 1 year high of $32.00. The business's 50 day moving average is $22.85 and its 200 day moving average is $24.99. The stock has a market cap of $320.38 million, a price-to-earnings ratio of -15.80 and a beta of 0.59.
TruBridge (NASDAQ:TBRG - Get Free Report) last released its quarterly earnings results on Friday, May 9th. The company reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.08). The business had revenue of $87.21 million during the quarter, compared to the consensus estimate of $86.21 million. TruBridge had a positive return on equity of 0.33% and a negative net margin of 5.86%. As a group, research analysts forecast that TruBridge, Inc. will post 0.07 EPS for the current fiscal year.
Insider Buying and Selling at TruBridge
In related news, CEO Christopher L. Fowler sold 6,000 shares of the company's stock in a transaction on Friday, May 16th. The stock was sold at an average price of $25.05, for a total transaction of $150,300.00. Following the transaction, the chief executive officer directly owned 131,090 shares of the company's stock, valued at approximately $3,283,804.50. The trade was a 4.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 10.70% of the stock is currently owned by corporate insiders.
TruBridge Company Profile
(
Free Report)
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Featured Stories

Before you consider TruBridge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.
While TruBridge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.